Movatterモバイル変換


[0]ホーム

URL:


GB0314479D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0314479D0
GB0314479D0GBGB0314479.7AGB0314479AGB0314479D0GB 0314479 D0GB0314479 D0GB 0314479D0GB 0314479 AGB0314479 AGB 0314479AGB 0314479 D0GB0314479 D0GB 0314479D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0314479.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group LtdfiledCriticalGlaxo Group Ltd
Priority to GBGB0314479.7ApriorityCriticalpatent/GB0314479D0/en
Publication of GB0314479D0publicationCriticalpatent/GB0314479D0/en
Priority to PCT/EP2004/006593prioritypatent/WO2004113301A1/en
Ceasedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

GBGB0314479.7A2003-06-202003-06-20CompoundsCeasedGB0314479D0 (en)

Priority Applications (2)

Application NumberPriority DateFiling DateTitle
GBGB0314479.7AGB0314479D0 (en)2003-06-202003-06-20Compounds
PCT/EP2004/006593WO2004113301A1 (en)2003-06-202004-06-17Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
GBGB0314479.7AGB0314479D0 (en)2003-06-202003-06-20Compounds

Publications (1)

Publication NumberPublication Date
GB0314479D0true GB0314479D0 (en)2003-07-23

Family

ID=27637067

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GBGB0314479.7ACeasedGB0314479D0 (en)2003-06-202003-06-20Compounds

Country Status (2)

CountryLink
GB (1)GB0314479D0 (en)
WO (1)WO2004113301A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
PL1828154T3 (en)*2004-12-092009-10-30Hoffmann La RochePhenyl-piperazin methanone derivatives
DK1830833T3 (en)*2004-12-162010-05-17Janssen Pharmaceutica Nv Combination of a glycine transporter (GLyT1) inhibitor and an antipsychotic for the treatment of symptoms of schizophrenia and its preparation and use
CA2595605A1 (en)2005-01-262006-08-03F. Hoffmann-La Roche AgPhenyl methanone derivatives and their use as glycine transporter 1 inhibitors
US8420670B2 (en)2007-08-222013-04-16Abbott Laboratories4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy
EP2527328A1 (en)2008-04-012012-11-28Abbott GmbH & Co. KGTetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
TW201038569A (en)2009-02-162010-11-01Abbott Gmbh & Co KgHeterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
AR075442A1 (en)2009-02-162011-03-30Abbott Gmbh & Co Kg AMINOTETRALINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USES IN THERAPY
US8877794B2 (en)2010-08-132014-11-04Abbott LaboratoriesPhenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8883839B2 (en)2010-08-132014-11-11Abbott LaboratoriesTetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9045459B2 (en)*2010-08-132015-06-02AbbVie Deutschland GmbH & Co. KGPhenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US8846743B2 (en)2010-08-132014-09-30Abbott LaboratoriesAminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9051280B2 (en)2010-08-132015-06-09AbbVie Deutschland GmbH & Co. KGTetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
US9309200B2 (en)2011-05-122016-04-12AbbVie Deutschland GmbH & Co. KGBenzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
CA2844275A1 (en)2011-08-052013-02-14AbbVie Deutschland GmbH & Co. KGAminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
JP2014533675A (en)2011-11-182014-12-15アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー N-substituted aminobenzocycloheptene, aminotetralin, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9365512B2 (en)2012-02-132016-06-14AbbVie Deutschland GmbH & Co. KGIsoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
US9650334B2 (en)2013-03-152017-05-16Abbvie Inc.Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
US9656955B2 (en)2013-03-152017-05-23Abbvie Inc.Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
WO2015055770A1 (en)2013-10-172015-04-23AbbVie Deutschland GmbH & Co. KGAminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
MX2016004934A (en)2013-10-172016-12-20Abbvie DeutschlandAminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy.
US9550754B2 (en)2014-09-112017-01-24AbbVie Deutschland GmbH & Co. KG4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
DE3276313D1 (en)*1981-09-241987-06-19Beecham Wuelfing Gmbh & Co KgSulphonamides
AU2001290786A1 (en)*2000-09-142002-03-26Gliatech, Inc.Nitrogen-containing compounds and their use as glycine transport inhibitors
GB0130696D0 (en)*2001-12-212002-02-06Smithkline Beecham PlcChemical Compounds

Also Published As

Publication numberPublication date
WO2004113301A1 (en)2004-12-29

Similar Documents

PublicationPublication DateTitle
GB0316915D0 (en)Compounds
GB0309781D0 (en)Compounds
GB0315950D0 (en)Compounds
GB0305559D0 (en)Compounds
GB0317268D0 (en)Compounds
GB0314476D0 (en)Compounds
GB0314479D0 (en)Compounds
GB0314478D0 (en)Compounds
EP1689403A4 (en)Heteroaryl-hydrazone compounds
GB0304665D0 (en)Compounds
GB0317498D0 (en)Compounds
GB0305553D0 (en)Compounds
GB0313915D0 (en)Compounds
GB0306329D0 (en)Compounds
GB0313914D0 (en)Compounds
EP1682514A4 (en)11- o-methylgeldanamycin compounds
GB0302512D0 (en)Compounds
GB0304494D0 (en)Compounds
GB0317269D0 (en)Compounds
GB0301916D0 (en)Compounds
GB0314698D0 (en)Compounds
GB0307998D0 (en)Compounds
GB0308017D0 (en)Compounds
GB0306595D0 (en)Compounds
GB0305721D0 (en)Compounds

Legal Events

DateCodeTitleDescription
ATApplications terminated before publication under section 16(1)

[8]ページ先頭

©2009-2025 Movatter.jp